US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Personalized Medicine Market Research Reports & Industry Analysis

RSS Feeds

Personalized Medicine Industry Research & Market Reports

  2  next >
Personalized Medicines
3/1/2014 | published by: Global Industry Analysts
... US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2011 through 2020. Market data and analytics are derived from primary and secondary research. Company profiles are ...  |  read more...
USD 4,950
The 2013-2018 Outlook for Genetic Testing Services in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or ...  |  read more...
USD 495
Future of Personalized Genomics-Technical Insights
3/31/2014 | published by: Frost & Sullivan
... a while host of indications. Embracing genetic best tests, will help world economies by reducing the millions of dollars spent in present diagnostic approaches. Preventative healthcare will also become a more concrete lifestyle choice due ...  |  read more...
USD 6,500
Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
9/30/2013 | published by: MarketsandMarkets
... significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 ...  |  read more...
USD 4,650
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) Market & Forecast
6/13/2013 | published by: Renub Research
... as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 ...  |  read more...
USD 1,400
Predictive Diagnostics
9/1/2013 | published by: Global Industry Analysts
... are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 58 companies including many key and niche players such as Abbott Molecular, Almac Group ...  |  read more...
USD 4,500
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)
4/1/2009 | published by: Kalorama Information
... personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this ...  |  read more...
USD 995
SNP Genotyping and Analysis Markets and the Future of SNPs in Personalized Medicine
2/1/2010 | published by: Kalorama Information
... exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and ...  |  read more...
USD 1,995
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
... the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara ...  |  read more...
USD 3,500
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine)
6/1/2008 | published by: Kalorama Information
... the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as ...  |  read more...
USD 2,995
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine
1/1/2011 | published by: JZMed, Inc.
... Their efforts are leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and diagnostics. However, it’s the genomics ...  |  read more...
USD 3,285
Companion Diagnostics – Streamlining Drug Development and Advancing Personalized Medicine
4/1/2013 | published by: CBR Pharma Insights, LLC
... to gain ground. Companion diagnostics can be used in screening, monitoring, diagnosing and treating patients and can allow for stratification of patients to maximize efficacy and minimize risk Companion diagnostics can allow for a specific ...  |  read more...
USD 3,900
Cancer Peptides: From First-in-Class to Best-in-Class?
1/7/2013 | published by: BioSeeker Group AB
... Which targets, tumor types and companies are setting the path? What is first-in-class in the cancer peptide pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and ...  |  read more...
USD 3,675
Personalized Medicine for Cancer
9/30/2011 | published by: GlobalData
... The report also provides insights on the companion diagnostics and marketed personalized drugs for cancer. Scope The report provides information on the concept of personalized medicines, Challenges in development of personalized medicine and Benefits of ...  |  read more...
USD 500
Biomarkers Market Discovery Technologies (Proteomics, Genomics, Imaging, Bioinformatics), Applications (Drug Discovery, Personalized Medicine, Molecular Diagnostics) & Indications (Cancer, Cardiovascular & Neural) Global Trends & Forecasts (2011 - 2020)
2/2/2012 | published by: MarketsandMarkets
... based on different parameters such as on the basis of their application, their characteristics and on their usage in decision making in early drug development. With drug development facing challenges from ever increasing cost of ...  |  read more...
USD 4,650
Companion Diagnostics - Increased Focus on Personalized Medicine and Favorable Regulatory Environment to Drive Market Growth
3/27/2012 | published by: GlobalData
... provides information and analysis on the global companion diagnostics market. The report provides information such as current trends and developments in the global companion diagnostics market (including recent deals and industry trends). The report also ...  |  read more...
USD 500
Personalized Medicine: Companies, Trends and World Market
4/1/2012 | published by: Takeda Pacific
... report examines key market segments such as targeted drugs and key personalized medicine diagnostics, including companion diagnostic IVDs, LDTs, diagnostic services and related tools or technologies. Many people already know about DNA, genes and the ...  |  read more...
USD 2,495
Companion Diagnostics and Personalized Medicine Market Report 2012
8/1/2012 | published by: Select Biosciences Limited
... aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine. Companion Diagnostics has been rapidly expanding over the past 3 years and in this ...  |  read more...
USD 1,970
Personalized Medicine - A Global Market Overview
8/15/2012 | published by: Industry Experts
... factor, since everybody wants caregivers who can comprehend an individual’s problems. The day is not very far when this level of personal or individual understanding between a patient and a doctor would be much deeper ...  |  read more...
USD 3,600
Breast Cancer Therapies Markets
11/1/2012 | published by: TriMark Publications
... such barriers to entry as a stringent regulatory environment and the incursion of cost containment within oncology. Breast Cancer Therapies Markets provides comprehensive information on major and minor shapers of the breast cancer drug treatment ...  |  read more...
USD 3,400
The Impact of Health and Wellness on Products and Services
6/13/2012 | published by: Frost & Sullivan
... and openness and transparency - have been discussed. These four have been shortlisted among the others because greener products would have higher acceptance and increased demand, digitalization would be the key to reduce growing healthcare ...  |  read more...
USD 6,000
  2  next >